MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines

The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production rema...

Full description

Saved in:
Bibliographic Details
Published in:Cell research Vol. 23; no. 11; pp. 1270 - 1283
Main Authors: Sun, Yang, Li, Qi, Gui, Huan, Xu, Dong-Ping, Yang, Yi-Li, Su, Ding-Feng, Liu, Xia
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01.11.2013
Nature Publishing Group
Subjects:
ISSN:1001-0602, 1748-7838, 1748-7838
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-o converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
AbstractList The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-o converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the alpha 7-nicotinic acetylcholine receptor ( alpha 7nAChR) on macrophages. However, the intracellular mechanisms that link alpha 7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF- alpha converting enzyme (TACE) to reduce TNF- alpha release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
Author Yang Sun Qi Li Huan Gui Dong-Ping Xu Yi-LiYang Ding-Feng Su Xia Liu
AuthorAffiliation Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
Author_xml – sequence: 1
  givenname: Yang
  surname: Sun
  fullname: Sun, Yang
  organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University
– sequence: 2
  givenname: Qi
  surname: Li
  fullname: Li, Qi
  organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University
– sequence: 3
  givenname: Huan
  surname: Gui
  fullname: Gui, Huan
  organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University
– sequence: 4
  givenname: Dong-Ping
  surname: Xu
  fullname: Xu, Dong-Ping
  organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University
– sequence: 5
  givenname: Yi-Li
  surname: Yang
  fullname: Yang, Yi-Li
  email: yiliyang@mail.nih.gov
  organization: Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health
– sequence: 6
  givenname: Ding-Feng
  surname: Su
  fullname: Su, Ding-Feng
  email: dfsu2008@gmail.com
  organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University
– sequence: 7
  givenname: Xia
  surname: Liu
  fullname: Liu, Xia
  email: lxflying@aliyun.com
  organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23979021$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1vFSEUhiemxn7oyr0Z48ZE58oBBoZNk6bxK6maGF0ThmFmqHPhFhiTu_G3y3hvm7bpwhUQnvfJgXOOiwPnnSmK54BWgEjzTocVRkBWAOxRcQScNhVvSHOQ9whBhRjCh8VxjJcI4ZrW8KQ4xERwgTAcFX--WB38969nFWBark1nVTKxTKMp9egn60wYrC6VS7ayrp_Ueq2SD9tS6WS9y2Dw8zCW1o22tcm64V92E3w37wjfL6e7Yb1N_ld2x6fF415N0TzbryfFzw_vf5x_qi6-ffx8fnZR6ZpDqhTvuTG0boWGDmNkRI87AqCZYaI10CuDGtbpugWiasZEvu2wYkbUgiiByUlxuvNu5jY_UhuXgprkJti1ClvplZV3b5wd5eB_S9IArynNgtd7QfBXs4lJrm3UZpqUM36OEiijNSKIwH-gVOAG5-Zk9NU99NLPweWfWKgGU8TxInxxu_ibqq-7mAHYAbmVMQbTS22TWn4_v8VOEpBcJkXqIJdJkXlScubNvcy19mH67Y6OmXKDCbcKfRB_uZeP3g1XOXFjp5wz0TBE_gKsatp1
CitedBy_id crossref_primary_10_1016_j_tcm_2019_10_011
crossref_primary_10_1371_journal_pone_0164207
crossref_primary_10_1371_journal_pone_0193609
crossref_primary_10_1038_srep37709
crossref_primary_10_1016_j_trsl_2017_10_004
crossref_primary_10_1016_j_intimp_2021_108262
crossref_primary_10_1016_j_biopha_2020_110736
crossref_primary_10_1016_j_brainres_2015_08_029
crossref_primary_10_1097_SHK_0000000000000604
crossref_primary_10_1155_2014_283525
crossref_primary_10_1007_s00284_024_03977_2
crossref_primary_10_1016_j_jneuroim_2016_04_014
crossref_primary_10_1186_s12950_025_00443_z
crossref_primary_10_1165_rcmb_2016_0270OC
crossref_primary_10_1007_s00705_015_2351_0
crossref_primary_10_1038_s41598_018_35254_1
crossref_primary_10_1242_dev_170670
crossref_primary_10_1016_j_intimp_2016_01_009
crossref_primary_10_1016_j_neuroscience_2016_12_017
crossref_primary_10_1016_j_neulet_2018_07_022
crossref_primary_10_1016_j_drudis_2020_12_019
crossref_primary_10_3389_fncel_2015_00193
crossref_primary_10_1111_jvh_12284
crossref_primary_10_1016_j_abb_2021_108806
crossref_primary_10_1080_17501911_2025_2548762
crossref_primary_10_1134_S1062359023604780
crossref_primary_10_1016_j_brainres_2017_02_018
crossref_primary_10_1038_s41392_019_0061_x
crossref_primary_10_1186_s13054_016_1555_3
crossref_primary_10_1007_s12035_017_0584_5
crossref_primary_10_1016_j_jconrel_2016_06_005
crossref_primary_10_3389_fimmu_2020_00235
crossref_primary_10_1007_s40291_022_00598_y
crossref_primary_10_1007_s00441_015_2183_y
crossref_primary_10_1016_j_expneurol_2020_113382
crossref_primary_10_1371_journal_pone_0254657
crossref_primary_10_3389_fimmu_2021_669566
crossref_primary_10_1007_s43032_023_01204_0
crossref_primary_10_1016_j_jneuroim_2019_04_012
crossref_primary_10_1002_smll_202107534
crossref_primary_10_3389_fimmu_2021_798713
crossref_primary_10_1002_adfm_202305558
crossref_primary_10_3892_ijmm_2016_2613
crossref_primary_10_1016_j_autrev_2024_103739
crossref_primary_10_1097_IN9_0000000000000027
crossref_primary_10_1007_s00109_016_1473_5
crossref_primary_10_1155_2021_9059601
crossref_primary_10_3389_fimmu_2025_1565068
crossref_primary_10_3389_fncel_2024_1365448
crossref_primary_10_3892_ijo_2023_5594
crossref_primary_10_1002_rmv_70026
crossref_primary_10_1038_s41598_021_89605_6
crossref_primary_10_1016_j_pneurobio_2017_03_004
crossref_primary_10_1186_s12974_018_1053_4
crossref_primary_10_1371_journal_pone_0160743
crossref_primary_10_1186_s12882_024_03688_7
crossref_primary_10_1016_j_bbrc_2017_03_106
crossref_primary_10_1016_j_diagmicrobio_2023_116053
crossref_primary_10_1002_mds_27928
crossref_primary_10_1007_s10571_025_01578_6
crossref_primary_10_1016_j_intimp_2025_115334
crossref_primary_10_1038_cddis_2016_426
crossref_primary_10_1016_j_nano_2015_10_011
crossref_primary_10_1007_s40520_019_01359_4
crossref_primary_10_1186_s40360_024_00749_3
crossref_primary_10_1016_j_ibmb_2018_11_004
crossref_primary_10_1016_j_molmed_2017_10_006
crossref_primary_10_1155_2022_1885066
crossref_primary_10_1016_j_scitotenv_2022_158777
crossref_primary_10_1136_annrheumdis_2022_222228
crossref_primary_10_1093_cid_ciab733
crossref_primary_10_1016_j_intimp_2021_107791
crossref_primary_10_1002_1873_3468_13789
crossref_primary_10_1097_MD_0000000000016470
crossref_primary_10_1016_j_ajog_2014_04_026
crossref_primary_10_1016_j_jaut_2022_102948
crossref_primary_10_2174_1381612826666200617163857
crossref_primary_10_3389_fcell_2021_732952
crossref_primary_10_1016_j_intimp_2024_113267
crossref_primary_10_1002_glia_23484
crossref_primary_10_1002_adfm_202401547
crossref_primary_10_1177_2058739218798463
crossref_primary_10_4049_jimmunol_1402088
crossref_primary_10_1007_s11064_021_03456_1
crossref_primary_10_31083_j_jin2202031
crossref_primary_10_1007_s10238_025_01588_0
crossref_primary_10_1016_j_arr_2024_102267
crossref_primary_10_3390_ijms21165801
crossref_primary_10_1016_j_phymed_2021_153745
crossref_primary_10_1002_cbf_3386
crossref_primary_10_1002_smll_202410162
crossref_primary_10_3389_fphar_2016_00290
crossref_primary_10_1016_j_ijpharm_2018_09_063
crossref_primary_10_1080_14728222_2018_1420166
crossref_primary_10_1158_0008_5472_CAN_20_1599
crossref_primary_10_3389_fncel_2017_00316
crossref_primary_10_1016_j_phrs_2023_106870
crossref_primary_10_3390_biomedicines11051417
crossref_primary_10_1038_s41598_018_37813_y
crossref_primary_10_1007_s10753_018_0896_2
crossref_primary_10_1007_s00011_024_01987_1
crossref_primary_10_4049_jimmunol_2200192
crossref_primary_10_1007_s10753_024_02125_z
crossref_primary_10_1111_joim_12611
crossref_primary_10_3389_fncel_2016_00125
crossref_primary_10_14309_ctg_0000000000000560
crossref_primary_10_1186_s12984_025_01700_1
crossref_primary_10_1136_annrheumdis_2014_206417
crossref_primary_10_1002_EXP_20230165
crossref_primary_10_2174_0113816128244442231018070639
crossref_primary_10_1002_oby_22298
crossref_primary_10_1111_jnc_15332
crossref_primary_10_1007_s11064_018_02714_z
crossref_primary_10_1016_j_freeradbiomed_2021_06_007
crossref_primary_10_3389_fnagi_2018_00220
crossref_primary_10_55095_achot2022_059
crossref_primary_10_1155_2019_8243813
crossref_primary_10_1016_j_autrev_2025_103820
crossref_primary_10_1016_j_omtn_2020_05_012
crossref_primary_10_1080_08830185_2020_1779712
crossref_primary_10_3389_fimmu_2017_01452
crossref_primary_10_1186_s40635_016_0091_4
crossref_primary_10_1186_s13071_022_05164_3
crossref_primary_10_1016_j_omtn_2021_10_030
crossref_primary_10_1007_s10753_020_01396_6
crossref_primary_10_1016_j_micpath_2025_107914
crossref_primary_10_3389_fimmu_2020_590870
crossref_primary_10_1093_ibd_izad211
crossref_primary_10_3390_ijms222413427
crossref_primary_10_1016_j_xphs_2021_01_024
crossref_primary_10_1016_j_heliyon_2023_e21615
crossref_primary_10_1038_cr_2013_128
crossref_primary_10_1007_s11481_017_9760_7
crossref_primary_10_1021_acsbiomaterials_8b01510
crossref_primary_10_1177_1073858417721150
crossref_primary_10_1007_s11033_025_10288_7
crossref_primary_10_3389_fimmu_2018_01377
crossref_primary_10_1016_j_molmed_2016_07_001
crossref_primary_10_1007_s12035_017_0843_5
crossref_primary_10_1016_j_cej_2024_153407
crossref_primary_10_1124_pr_113_008581
crossref_primary_10_3109_01902148_2015_1004206
crossref_primary_10_3390_diseases9020029
crossref_primary_10_3390_ijms25179475
crossref_primary_10_1016_j_heliyon_2023_e22914
crossref_primary_10_1016_j_kint_2018_09_020
crossref_primary_10_1111_nmo_13288
crossref_primary_10_1080_15384101_2019_1638182
crossref_primary_10_1080_10717544_2020_1731861
crossref_primary_10_3390_ijms232415479
crossref_primary_10_1016_j_ejphar_2020_173315
crossref_primary_10_1007_s00018_022_04398_9
crossref_primary_10_1080_21691401_2019_1624559
crossref_primary_10_1038_srep18648
crossref_primary_10_3389_fimmu_2021_653344
crossref_primary_10_3390_pharmaceutics14020258
crossref_primary_10_3389_fcvm_2021_696413
crossref_primary_10_1007_s10157_024_02525_3
crossref_primary_10_1016_j_biopha_2018_05_076
crossref_primary_10_1007_s00011_022_01614_x
crossref_primary_10_1371_journal_pone_0163645
crossref_primary_10_1016_j_neuroscience_2014_02_011
crossref_primary_10_1016_j_exger_2021_111578
crossref_primary_10_1038_aps_2016_16
crossref_primary_10_3390_molecules26040944
crossref_primary_10_1016_j_oooo_2016_03_018
crossref_primary_10_1016_j_ejphar_2018_06_028
crossref_primary_10_3389_fimmu_2019_00565
crossref_primary_10_1016_j_imlet_2016_08_006
crossref_primary_10_1038_npp_2016_167
crossref_primary_10_1021_acsbiomaterials_9b01550
crossref_primary_10_3390_separations10020076
crossref_primary_10_1159_000528502
crossref_primary_10_3390_ijms22094956
crossref_primary_10_3389_fimmu_2020_595342
crossref_primary_10_3390_ijms18091830
crossref_primary_10_1016_j_pharmthera_2017_05_002
crossref_primary_10_3389_fimmu_2016_00406
crossref_primary_10_3390_ijms23147611
crossref_primary_10_2478_jtim_2019_0011
crossref_primary_10_3389_fimmu_2022_1014013
crossref_primary_10_3389_fphar_2020_602999
Cites_doi 10.1084/jem.20052362
10.1523/JNEUROSCI.23-27-09024.2003
10.1038/nature01339
10.1038/nature08199
10.1093/intimm/dxr034
10.4049/jimmunol.179.5.2686
10.1146/annurev-immunol-020711-075013
10.4049/jimmunol.1100013
10.1038/nri2691
10.4161/cc.8.13.8816
10.1056/NEJMra021333
10.1038/nrd1797
10.1038/nm1124
10.1038/ni.1742
10.1042/bj20020588
10.1038/nature01320
10.1016/j.cyto.2008.07.006
10.1038/bjp.2008.185
10.1186/1476-4598-9-309
10.1038/nm.2266
10.1073/pnas.0803237105
10.1007/s13105-010-0050-6
10.1038/ni1229
10.4049/jimmunol.176.2.721
10.1517/13543784.9.1.103
10.1016/j.ccr.2009.02.015
10.1038/nature07201
10.1038/385733a0
10.1152/ajpcell.00160.2009
10.1146/annurev-immunol-020711-075015
10.1038/nature02738
10.1523/JNEUROSCI.2444-07.2007
10.1016/j.cell.2011.10.043
10.1126/science.1209985
10.1038/35013070
10.1007/s11095-010-0283-7
10.1007/s00395-013-0345-1
10.1002/art.23987
10.4049/jimmunol.0900707
10.1016/j.molimm.2009.02.018
10.1146/annurev.immunol.20.082401.104914
10.1002/stem.1154
10.1073/pnas.0709971104
10.1016/j.coph.2009.05.003
10.1002/eji.201040540
10.1186/1479-5876-9-129
10.1159/000329982
10.4049/jimmunol.179.8.5082
10.1038/nri802
10.1124/mol.105.018481
10.1177/000313481207800102
ContentType Journal Article
Copyright The Author(s) 2013
Copyright Nature Publishing Group Nov 2013
Copyright © 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Copyright_xml – notice: The Author(s) 2013
– notice: Copyright Nature Publishing Group Nov 2013
– notice: Copyright © 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
DBID 2RA
92L
CQIGP
W94
WU4
~WA
C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7QP
7QR
7T5
7TK
7TM
7TO
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOI 10.1038/cr.2013.116
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-自然科学
中文科技期刊数据库-自然科学-生物科学
中文科技期刊数据库- 镜像站点
Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection (ProQuest)
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Databases
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


AIDS and Cancer Research Abstracts
MEDLINE
ProQuest Central Student
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines
miR-124 and the cholinergic anti-inflammation
EISSN 1748-7838
EndPage 1283
ExternalDocumentID PMC3817544
3116501101
23979021
10_1038_cr_2013_116
47769860
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-01
-0A
-Q-
-SA
-S~
0R~
29B
2B.
2C.
2RA
2WC
36B
39C
3V.
4.4
406
53G
5GY
5VR
5XA
5XB
5XL
6J9
70F
7X7
88E
8FE
8FH
8FI
8FJ
92E
92I
92L
92M
92Q
93N
9D9
9DA
AADWK
AANZL
AATNV
AAWBL
AAYFA
AAYJO
AAZLF
ABAWZ
ABGIJ
ABJNI
ABUWG
ACAOD
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACIWK
ACKTT
ACPRK
ACRQY
ACTTH
ACVWB
ACZOJ
ADBBV
ADFRT
ADHDB
ADMDM
ADQMX
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AESKC
AEVLU
AEXYK
AFKRA
AFNRJ
AFRAH
AFSHS
AFUIB
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AILAN
AJCLW
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
AOIJS
AXYYD
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
C1A
CAG
CAJEA
CAJUS
CCEZO
CCPQU
CCVFK
CHBEP
COF
CQIGP
CS3
CW9
DIK
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FA0
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JUIAU
JZLTJ
KQ8
LK8
M1P
M7P
NAO
NQJWS
NXXTH
NYICJ
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
Q--
Q-0
R-A
RNS
RNT
RNTTT
RPM
RT1
S..
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
T8Q
TAOOD
TBHMF
TCJ
TDRGL
TGP
TR2
U1F
U1G
U5A
U5K
UKHRP
W94
WFFXF
WU4
XSB
~88
~WA
AACDK
AAHBH
AASML
AAXDM
AAYZH
ABAKF
ABZZP
ACMJI
AEFQL
AEMSY
AEUYN
AFBBN
AGQEE
AIGIU
ALIPV
C6C
FIGPU
LGEZI
LOTEE
NADUK
ROL
SOJ
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFFHD
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7QP
7QR
7T5
7TK
7TM
7TO
7U9
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c571t-a7f7ee45b9c1d220e9f2d311c6e69be1fae086dc5b13a56692d3d2a6e9593a923
IEDL.DBID M7P
ISICitedReferencesCount 214
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000326683600009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1001-0602
1748-7838
IngestDate Tue Nov 04 01:53:44 EST 2025
Thu Oct 02 05:11:28 EDT 2025
Thu Nov 20 07:38:45 EST 2025
Sat Nov 29 14:28:39 EST 2025
Mon Jul 21 05:57:12 EDT 2025
Tue Nov 18 22:28:30 EST 2025
Sat Nov 29 05:46:52 EST 2025
Fri Feb 21 02:38:10 EST 2025
Wed Feb 14 10:38:19 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords macrophages
septic shock
α7nAChR
cholinergic anti-inflammatory action
STAT3
TACE
micorRNA-124
Language English
License https://creativecommons.org/licenses/by-nc-nd/3.0
This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c571t-a7f7ee45b9c1d220e9f2d311c6e69be1fae086dc5b13a56692d3d2a6e9593a923
Notes The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-o converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
31-1568/Q
microRNA-124; cholinergic anti-inflammatory action; ct7nAChR; macrophages; septic shock; STAT3; TACE
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
These two authors contributed equally to this work.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3817544
PMID 23979021
PQID 1448240721
PQPubID 536307
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3817544
proquest_miscellaneous_1464503031
proquest_miscellaneous_1449282100
proquest_journals_1448240721
pubmed_primary_23979021
crossref_citationtrail_10_1038_cr_2013_116
crossref_primary_10_1038_cr_2013_116
springer_journals_10_1038_cr_2013_116
chongqing_primary_47769860
PublicationCentury 2000
PublicationDate 2013-11-01
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-11-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell research
PublicationTitleAbbrev Cell Res
PublicationTitleAlternate Cell Research
PublicationYear 2013
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Smookler, Mohammed, Kassiri, Duncan, Mak, Khokha (CR27) 2006; 176
Marrero, Bencherif, Lippiello, Lucas (CR9) 2011; 28
Fry (CR33) 2012; 78
Hotchkiss, Karl (CR29) 2003; 348
Hou, Wang, Lin (CR50) 2009; 183
Karginov, Conaco, Xuan (CR16) 2007; 104
Quinn, O'Neill (CR23) 2011; 23
Bitner, Bunnelle, Anderson (CR13) 2007; 27
Tili, Michaille, Cimino (CR22) 2007; 179
Samavati, Rastogi, Du, Huttemann, Fite, Franchi (CR43) 2009; 46
Lee, Lim, Sakong, Lee, Kim, Baek (CR44) 2006; 69
Feldmann (CR30) 2002; 2
Van Assche, Rutgeerts (CR31) 2000; 9
Waldburger, Boyle, Pavlov, Tracey, Firestein (CR19) 2008; 58
Webster, Tonelli, Sternberg (CR3) 2002; 20
O'Connell, Rao, Baltimore (CR17) 2012; 30
Borovikova, Ivanova, Zhang (CR4) 2000; 405
Huang, Shen, Zou, Wang, Tang, Zhang (CR15) 2011; 67
Rosas-Ballina, Ochani, Parrish (CR25) 2008; 105
Horiuchi, Kimura, Miyamoto (CR28) 2007; 179
Wessler, Kirkpatrick (CR11) 2008; 154
Wang, Chen, Zhang (CR51) 2009; 10
Zhao, He, Bi, Yu, Gil Wier, Zang (CR10) 2013; 108
Pena, Cai, Liu (CR42) 2010; 40
Yamamoto, Yamazaki, Uematsu (CR37) 2004; 430
Chatterjee, Al-Abed, Sherry, Metz (CR40) 2009; 297
Yu, Zhang, Kone (CR45) 2002; 367
Wang, Yu, Ochani (CR14) 2003; 421
Huston, Ochani, Rosas-Ballina (CR24) 2006; 203
Lakhan, Kirchgessner (CR35) 2011; 9
Lindenblatt, Schulze-Osthoff, Totzke (CR36) 2009; 8
Li, Zhou, Kolosov, Perelman (CR38) 2011; 27
de Jonge, van der Zanden, The (CR41) 2005; 6
Pena, Cai, Ramos, Vida, Deitch, Ulloa (CR7) 2011; 187
Ponomarev, Veremeyko, Barteneva, Krichevsky, Weiner (CR20) 2011; 17
Khiroug, Giniatullin, Klein, Fayuk, Yakel (CR12) 2003; 23
Suzuki, Yamagata, Sugimoto, Iwamoto, Kato, Miyazono (CR18) 2009; 460
Sims, Smith (CR32) 2010; 10
Lee, Herrmann, Deng (CR46) 2009; 15
Huang, Yeh, Lin (CR47) 2010; 9
Rosas-Ballina, Olofsson, Ochani (CR6) 2011; 334
Park, Baik, Cho, Kim, Lee, Han (CR39) 2008; 44
Hatziapostolou, Polytarchou, Aggelidou (CR49) 2011; 147
Tsitsiou, Lindsay (CR21) 2009; 9
Cai, Li, Wang (CR48) 2012; 30
Ulloa (CR5) 2005; 4
Moss, Jin, Milla (CR26) 1997; 385
Wang, Liao, Ochani (CR8) 2004; 10
Andersson, Tracey (CR34) 2012; 30
Medzhitov (CR1) 2008; 454
Nathan (CR2) 2002; 420
I Wessler (BFcr2013116_CR11) 2008; 154
Q Li (BFcr2013116_CR38) 2011; 27
JE Sims (BFcr2013116_CR32) 2010; 10
FV Karginov (BFcr2013116_CR16) 2007; 104
JM Waldburger (BFcr2013116_CR19) 2008; 58
Y Huang (BFcr2013116_CR15) 2011; 67
SY Park (BFcr2013116_CR39) 2008; 44
WJ de Jonge (BFcr2013116_CR41) 2005; 6
DS Smookler (BFcr2013116_CR27) 2006; 176
G Pena (BFcr2013116_CR42) 2010; 40
C Lee (BFcr2013116_CR44) 2006; 69
RM O'Connell (BFcr2013116_CR17) 2012; 30
PK Chatterjee (BFcr2013116_CR40) 2009; 297
K Horiuchi (BFcr2013116_CR28) 2007; 179
M Rosas-Ballina (BFcr2013116_CR6) 2011; 334
SR Quinn (BFcr2013116_CR23) 2011; 23
M Feldmann (BFcr2013116_CR30) 2002; 2
C Nathan (BFcr2013116_CR2) 2002; 420
ED Ponomarev (BFcr2013116_CR20) 2011; 17
R Medzhitov (BFcr2013116_CR1) 2008; 454
RS Hotchkiss (BFcr2013116_CR29) 2003; 348
M Rosas-Ballina (BFcr2013116_CR25) 2008; 105
G Pena (BFcr2013116_CR7) 2011; 187
H Wang (BFcr2013116_CR8) 2004; 10
MB Marrero (BFcr2013116_CR9) 2011; 28
M Yamamoto (BFcr2013116_CR37) 2004; 430
SE Lakhan (BFcr2013116_CR35) 2011; 9
M Zhao (BFcr2013116_CR10) 2013; 108
H Wang (BFcr2013116_CR14) 2003; 421
H Lee (BFcr2013116_CR46) 2009; 15
L Ulloa (BFcr2013116_CR5) 2005; 4
ML Moss (BFcr2013116_CR26) 1997; 385
DE Fry (BFcr2013116_CR33) 2012; 78
J Hou (BFcr2013116_CR50) 2009; 183
JM Huston (BFcr2013116_CR24) 2006; 203
B Cai (BFcr2013116_CR48) 2012; 30
M Hatziapostolou (BFcr2013116_CR49) 2011; 147
JI Webster (BFcr2013116_CR3) 2002; 20
L Samavati (BFcr2013116_CR43) 2009; 46
U Andersson (BFcr2013116_CR34) 2012; 30
Z Yu (BFcr2013116_CR45) 2002; 367
WL Huang (BFcr2013116_CR47) 2010; 9
C Wang (BFcr2013116_CR51) 2009; 10
E Tili (BFcr2013116_CR22) 2007; 179
RS Bitner (BFcr2013116_CR13) 2007; 27
LV Borovikova (BFcr2013116_CR4) 2000; 405
E Tsitsiou (BFcr2013116_CR21) 2009; 9
HI Suzuki (BFcr2013116_CR18) 2009; 460
L Khiroug (BFcr2013116_CR12) 2003; 23
G Van Assche (BFcr2013116_CR31) 2000; 9
C Lindenblatt (BFcr2013116_CR36) 2009; 8
12057007 - Biochem J. 2002 Oct 1;367(Pt 1):97-105
12490957 - Nature. 2002 Dec 19-26;420(6917):846-52
17911593 - J Immunol. 2007 Oct 15;179(8):5082-9
21810260 - J Transl Med. 2011;9:129
17898229 - J Neurosci. 2007 Sep 26;27(39):10578-87
16785311 - J Exp Med. 2006 Jul 10;203(7):1623-8
11861600 - Annu Rev Immunol. 2002;20:125-63
18975306 - Arthritis Rheum. 2008 Nov;58(11):3439-49
22696253 - Stem Cells. 2012 Aug;30(8):1746-55
21666060 - J Immunol. 2011 Jul 15;187(2):718-25
20081871 - Nat Rev Immunol. 2010 Feb;10(2):89-102
16393953 - J Immunol. 2006 Jan 15;176(2):721-5
19626115 - Nature. 2009 Jul 23;460(7254):529-33
22224773 - Annu Rev Immunol. 2012;30:295-312
11060664 - Expert Opin Investig Drugs. 2000 Jan;9(1):103-11
19345327 - Cancer Cell. 2009 Apr 7;15(4):283-93
20981514 - J Physiol Biochem. 2011 Mar;67(1):129-39
19299019 - Mol Immunol. 2009 May;46(8-9):1867-77
15241416 - Nature. 2004 Jul 8;430(6996):218-22
19502795 - Cell Cycle. 2009 Jul 1;8(13):2019-23
18650913 - Nature. 2008 Jul 24;454(7203):428-35
24018376 - Cell Res. 2013 Nov;23(11):1249-50
18669662 - Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13
18042700 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19291-6
21921156 - Science. 2011 Oct 7;334(6052):98-101
19525145 - Curr Opin Pharmacol. 2009 Aug;9(4):514-20
18500366 - Br J Pharmacol. 2008 Aug;154(8):1558-71
16354768 - Mol Pharmacol. 2006 Mar;69(3):1041-7
19483718 - Nat Immunol. 2009 Jul;10(7):744-52
21691078 - Cell Physiol Biochem. 2011;27(5):605-12
21131957 - Nat Med. 2011 Jan;17(1):64-70
21122157 - Mol Cancer. 2010;9:309
12508119 - Nature. 2003 Jan 23;421(6921):384-8
18723372 - Cytokine. 2008 Oct;44(1):126-34
10839541 - Nature. 2000 May 25;405(6785):458-62
23519622 - Basic Res Cardiol. 2013 May;108(3):345
22153071 - Cell. 2011 Dec 9;147(6):1233-47
22224768 - Annu Rev Immunol. 2012;30:313-35
16025117 - Nat Immunol. 2005 Aug;6(8):844-51
20706987 - Eur J Immunol. 2010 Sep;40(9):2580-9
20859658 - Pharm Res. 2011 Feb;28(2):413-6
12033742 - Nat Rev Immunol. 2002 May;2(5):364-71
12519925 - N Engl J Med. 2003 Jan 9;348(2):138-50
15502843 - Nat Med. 2004 Nov;10(11):1216-21
19596990 - J Immunol. 2009 Aug 1;183(3):2150-8
19741199 - Am J Physiol Cell Physiol. 2009 Nov;297(5):C1294-306
17709479 - J Immunol. 2007 Sep 1;179(5):2686-9
21652514 - Int Immunol. 2011 Jul;23(7):421-5
14534236 - J Neurosci. 2003 Oct 8;23(27):9024-31
9034191 - Nature. 1997 Feb 20;385(6618):733-6
22273282 - Am Surg. 2012 Jan;78(1):1-8
16056392 - Nat Rev Drug Discov. 2005 Aug;4(8):673-84
References_xml – volume: 203
  start-page: 1623
  year: 2006
  end-page: 1628
  ident: CR24
  article-title: Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis
  publication-title: J Exp Med
  doi: 10.1084/jem.20052362
– volume: 23
  start-page: 9024
  year: 2003
  end-page: 9031
  ident: CR12
  article-title: Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-27-09024.2003
– volume: 421
  start-page: 384
  year: 2003
  end-page: 388
  ident: CR14
  article-title: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation
  publication-title: Nature
  doi: 10.1038/nature01339
– volume: 460
  start-page: 529
  year: 2009
  end-page: 533
  ident: CR18
  article-title: Modulation of microRNA processing by p53
  publication-title: Nature
  doi: 10.1038/nature08199
– volume: 23
  start-page: 421
  year: 2011
  end-page: 425
  ident: CR23
  article-title: A trio of microRNAs that control Toll-like receptor signalling
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxr034
– volume: 179
  start-page: 2686
  year: 2007
  end-page: 2689
  ident: CR28
  article-title: Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.5.2686
– volume: 30
  start-page: 295
  year: 2012
  end-page: 312
  ident: CR17
  article-title: MicroRNA regulation of inflammatory responses
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075013
– volume: 187
  start-page: 718
  year: 2011
  end-page: 725
  ident: CR7
  article-title: Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1100013
– volume: 10
  start-page: 89
  year: 2010
  end-page: 102
  ident: CR32
  article-title: The IL-1 family: regulators of immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2691
– volume: 8
  start-page: 2019
  year: 2009
  end-page: 2023
  ident: CR36
  article-title: Iκbζ expression is regulated by miR-124a
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.13.8816
– volume: 348
  start-page: 138
  year: 2003
  end-page: 150
  ident: CR29
  article-title: The pathophysiology and treatment of sepsis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra021333
– volume: 4
  start-page: 673
  year: 2005
  end-page: 684
  ident: CR5
  article-title: The vagus nerve and the nicotinic anti-inflammatory pathway
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd1797
– volume: 10
  start-page: 1216
  year: 2004
  end-page: 1221
  ident: CR8
  article-title: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
  publication-title: Nat Med
  doi: 10.1038/nm1124
– volume: 10
  start-page: 744
  year: 2009
  end-page: 752
  ident: CR51
  article-title: The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type 1 interferon
  publication-title: Nat Immunol
  doi: 10.1038/ni.1742
– volume: 367
  start-page: 97
  year: 2002
  end-page: 105
  ident: CR45
  article-title: Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB
  publication-title: Biochem J
  doi: 10.1042/bj20020588
– volume: 420
  start-page: 846
  year: 2002
  end-page: 852
  ident: CR2
  article-title: Points of control in inflammation
  publication-title: Nature
  doi: 10.1038/nature01320
– volume: 44
  start-page: 126
  year: 2008
  end-page: 134
  ident: CR39
  article-title: Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2008.07.006
– volume: 154
  start-page: 1558
  year: 2008
  end-page: 1571
  ident: CR11
  article-title: Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans
  publication-title: Br J Pharmacol
  doi: 10.1038/bjp.2008.185
– volume: 9
  start-page: 309
  year: 2010
  ident: CR47
  article-title: Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-9-309
– volume: 17
  start-page: 64
  year: 2011
  end-page: 70
  ident: CR20
  article-title: MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway
  publication-title: Nat Med
  doi: 10.1038/nm.2266
– volume: 105
  start-page: 11008
  year: 2008
  end-page: 11013
  ident: CR25
  article-title: Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0803237105
– volume: 67
  start-page: 129
  year: 2011
  end-page: 139
  ident: CR15
  article-title: Biological functions of microRNAs: a review
  publication-title: J Physiol Biochem
  doi: 10.1007/s13105-010-0050-6
– volume: 6
  start-page: 844
  year: 2005
  end-page: 851
  ident: CR41
  article-title: Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
  publication-title: Nat Immunol
  doi: 10.1038/ni1229
– volume: 176
  start-page: 721
  year: 2006
  end-page: 725
  ident: CR27
  article-title: Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.2.721
– volume: 9
  start-page: 103
  year: 2000
  end-page: 111
  ident: CR31
  article-title: Anti-TNF agents in crohn's disease
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.9.1.103
– volume: 15
  start-page: 283
  year: 2009
  end-page: 293
  ident: CR46
  article-title: Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2009.02.015
– volume: 454
  start-page: 428
  year: 2008
  end-page: 435
  ident: CR1
  article-title: Origin and physiological roles of inflammation
  publication-title: Nature
  doi: 10.1038/nature07201
– volume: 385
  start-page: 733
  year: 1997
  end-page: 736
  ident: CR26
  article-title: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha
  publication-title: Nature
  doi: 10.1038/385733a0
– volume: 297
  start-page: C1294
  year: 2009
  end-page: C1306
  ident: CR40
  article-title: Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00160.2009
– volume: 30
  start-page: 313
  year: 2012
  end-page: 335
  ident: CR34
  article-title: Reflex principles of immunological homeostasis
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075015
– volume: 430
  start-page: 218
  year: 2004
  end-page: 222
  ident: CR37
  article-title: Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta
  publication-title: Nature
  doi: 10.1038/nature02738
– volume: 27
  start-page: 10578
  year: 2007
  end-page: 10587
  ident: CR13
  article-title: Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK/2 and CREB phosphorylation pathways
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2444-07.2007
– volume: 147
  start-page: 1233
  year: 2011
  end-page: 1247
  ident: CR49
  article-title: An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis
  publication-title: Cell
  doi: 10.1016/j.cell.2011.10.043
– volume: 334
  start-page: 98
  year: 2011
  end-page: 101
  ident: CR6
  article-title: Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit
  publication-title: Science
  doi: 10.1126/science.1209985
– volume: 405
  start-page: 458
  year: 2000
  end-page: 462
  ident: CR4
  article-title: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
  publication-title: Nature
  doi: 10.1038/35013070
– volume: 69
  start-page: 1041
  year: 2006
  end-page: 1047
  ident: CR44
  article-title: Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production
  publication-title: Mol Pharmacol
– volume: 28
  start-page: 413
  year: 2011
  end-page: 416
  ident: CR9
  article-title: Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview
  publication-title: Pharm Res
  doi: 10.1007/s11095-010-0283-7
– volume: 108
  start-page: 345
  year: 2013
  ident: CR10
  article-title: Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-013-0345-1
– volume: 58
  start-page: 3439
  year: 2008
  end-page: 3449
  ident: CR19
  article-title: Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor
  publication-title: Arthritis Rheum
  doi: 10.1002/art.23987
– volume: 183
  start-page: 2150
  year: 2009
  end-page: 2158
  ident: CR50
  article-title: MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0900707
– volume: 46
  start-page: 1867
  year: 2009
  end-page: 1877
  ident: CR43
  article-title: STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2009.02.018
– volume: 20
  start-page: 125
  year: 2002
  end-page: 163
  ident: CR3
  article-title: Neuroendocrine regulation of immunity
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.20.082401.104914
– volume: 30
  start-page: 1746
  year: 2012
  end-page: 1755
  ident: CR48
  article-title: microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling
  publication-title: Stem Cells
  doi: 10.1002/stem.1154
– volume: 104
  start-page: 19291
  year: 2007
  end-page: 19296
  ident: CR16
  article-title: A biochemical approach to identifying microRNA targets
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0709971104
– volume: 9
  start-page: 514
  year: 2009
  end-page: 520
  ident: CR21
  article-title: MicroRNAs and the immune response
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2009.05.003
– volume: 40
  start-page: 2580
  year: 2010
  end-page: 2589
  ident: CR42
  article-title: Unphosphorylated STAT3 modulates α7 nicotinic receptor signaling and cytokine production in sepsis
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201040540
– volume: 9
  start-page: 129
  year: 2011
  ident: CR35
  article-title: Anti-inflammatory effects of nicotine in obesity and ulcerative colitis
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-9-129
– volume: 27
  start-page: 605
  year: 2011
  end-page: 612
  ident: CR38
  article-title: Nicotine reduces TNF-α expression through a α7 nAChR/MyD88/NF-κb pathway in HBE16 airway epithelial cells
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000329982
– volume: 179
  start-page: 5082
  year: 2007
  end-page: 5089
  ident: CR22
  article-title: Modulation of mir-155 and mir-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.8.5082
– volume: 78
  start-page: 1
  year: 2012
  end-page: 8
  ident: CR33
  article-title: Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues
  publication-title: Am Surg
– volume: 2
  start-page: 364
  year: 2002
  end-page: 371
  ident: CR30
  article-title: Development of anti-TNF therapy for rheumatoid arthritis
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri802
– volume: 30
  start-page: 295
  year: 2012
  ident: BFcr2013116_CR17
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075013
– volume: 421
  start-page: 384
  year: 2003
  ident: BFcr2013116_CR14
  publication-title: Nature
  doi: 10.1038/nature01339
– volume: 176
  start-page: 721
  year: 2006
  ident: BFcr2013116_CR27
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.2.721
– volume: 454
  start-page: 428
  year: 2008
  ident: BFcr2013116_CR1
  publication-title: Nature
  doi: 10.1038/nature07201
– volume: 27
  start-page: 605
  year: 2011
  ident: BFcr2013116_CR38
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000329982
– volume: 8
  start-page: 2019
  year: 2009
  ident: BFcr2013116_CR36
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.13.8816
– volume: 6
  start-page: 844
  year: 2005
  ident: BFcr2013116_CR41
  publication-title: Nat Immunol
  doi: 10.1038/ni1229
– volume: 27
  start-page: 10578
  year: 2007
  ident: BFcr2013116_CR13
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2444-07.2007
– volume: 179
  start-page: 2686
  year: 2007
  ident: BFcr2013116_CR28
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.5.2686
– volume: 15
  start-page: 283
  year: 2009
  ident: BFcr2013116_CR46
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2009.02.015
– volume: 385
  start-page: 733
  year: 1997
  ident: BFcr2013116_CR26
  publication-title: Nature
  doi: 10.1038/385733a0
– volume: 154
  start-page: 1558
  year: 2008
  ident: BFcr2013116_CR11
  publication-title: Br J Pharmacol
  doi: 10.1038/bjp.2008.185
– volume: 4
  start-page: 673
  year: 2005
  ident: BFcr2013116_CR5
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd1797
– volume: 430
  start-page: 218
  year: 2004
  ident: BFcr2013116_CR37
  publication-title: Nature
  doi: 10.1038/nature02738
– volume: 108
  start-page: 345
  year: 2013
  ident: BFcr2013116_CR10
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-013-0345-1
– volume: 23
  start-page: 421
  year: 2011
  ident: BFcr2013116_CR23
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxr034
– volume: 58
  start-page: 3439
  year: 2008
  ident: BFcr2013116_CR19
  publication-title: Arthritis Rheum
  doi: 10.1002/art.23987
– volume: 67
  start-page: 129
  year: 2011
  ident: BFcr2013116_CR15
  publication-title: J Physiol Biochem
  doi: 10.1007/s13105-010-0050-6
– volume: 9
  start-page: 514
  year: 2009
  ident: BFcr2013116_CR21
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2009.05.003
– volume: 9
  start-page: 103
  year: 2000
  ident: BFcr2013116_CR31
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.9.1.103
– volume: 69
  start-page: 1041
  year: 2006
  ident: BFcr2013116_CR44
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.105.018481
– volume: 147
  start-page: 1233
  year: 2011
  ident: BFcr2013116_CR49
  publication-title: Cell
  doi: 10.1016/j.cell.2011.10.043
– volume: 10
  start-page: 744
  year: 2009
  ident: BFcr2013116_CR51
  publication-title: Nat Immunol
  doi: 10.1038/ni.1742
– volume: 187
  start-page: 718
  year: 2011
  ident: BFcr2013116_CR7
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1100013
– volume: 179
  start-page: 5082
  year: 2007
  ident: BFcr2013116_CR22
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.8.5082
– volume: 10
  start-page: 89
  year: 2010
  ident: BFcr2013116_CR32
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2691
– volume: 367
  start-page: 97
  year: 2002
  ident: BFcr2013116_CR45
  publication-title: Biochem J
  doi: 10.1042/bj20020588
– volume: 23
  start-page: 9024
  year: 2003
  ident: BFcr2013116_CR12
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-27-09024.2003
– volume: 104
  start-page: 19291
  year: 2007
  ident: BFcr2013116_CR16
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0709971104
– volume: 44
  start-page: 126
  year: 2008
  ident: BFcr2013116_CR39
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2008.07.006
– volume: 40
  start-page: 2580
  year: 2010
  ident: BFcr2013116_CR42
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201040540
– volume: 28
  start-page: 413
  year: 2011
  ident: BFcr2013116_CR9
  publication-title: Pharm Res
  doi: 10.1007/s11095-010-0283-7
– volume: 10
  start-page: 1216
  year: 2004
  ident: BFcr2013116_CR8
  publication-title: Nat Med
  doi: 10.1038/nm1124
– volume: 17
  start-page: 64
  year: 2011
  ident: BFcr2013116_CR20
  publication-title: Nat Med
  doi: 10.1038/nm.2266
– volume: 348
  start-page: 138
  year: 2003
  ident: BFcr2013116_CR29
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra021333
– volume: 78
  start-page: 1
  year: 2012
  ident: BFcr2013116_CR33
  publication-title: Am Surg
  doi: 10.1177/000313481207800102
– volume: 30
  start-page: 313
  year: 2012
  ident: BFcr2013116_CR34
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075015
– volume: 105
  start-page: 11008
  year: 2008
  ident: BFcr2013116_CR25
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0803237105
– volume: 20
  start-page: 125
  year: 2002
  ident: BFcr2013116_CR3
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.20.082401.104914
– volume: 2
  start-page: 364
  year: 2002
  ident: BFcr2013116_CR30
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri802
– volume: 334
  start-page: 98
  year: 2011
  ident: BFcr2013116_CR6
  publication-title: Science
  doi: 10.1126/science.1209985
– volume: 297
  start-page: C1294
  year: 2009
  ident: BFcr2013116_CR40
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00160.2009
– volume: 460
  start-page: 529
  year: 2009
  ident: BFcr2013116_CR18
  publication-title: Nature
  doi: 10.1038/nature08199
– volume: 9
  start-page: 129
  year: 2011
  ident: BFcr2013116_CR35
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-9-129
– volume: 9
  start-page: 309
  year: 2010
  ident: BFcr2013116_CR47
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-9-309
– volume: 46
  start-page: 1867
  year: 2009
  ident: BFcr2013116_CR43
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2009.02.018
– volume: 183
  start-page: 2150
  year: 2009
  ident: BFcr2013116_CR50
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0900707
– volume: 405
  start-page: 458
  year: 2000
  ident: BFcr2013116_CR4
  publication-title: Nature
  doi: 10.1038/35013070
– volume: 420
  start-page: 846
  year: 2002
  ident: BFcr2013116_CR2
  publication-title: Nature
  doi: 10.1038/nature01320
– volume: 203
  start-page: 1623
  year: 2006
  ident: BFcr2013116_CR24
  publication-title: J Exp Med
  doi: 10.1084/jem.20052362
– volume: 30
  start-page: 1746
  year: 2012
  ident: BFcr2013116_CR48
  publication-title: Stem Cells
  doi: 10.1002/stem.1154
– reference: 16785311 - J Exp Med. 2006 Jul 10;203(7):1623-8
– reference: 19299019 - Mol Immunol. 2009 May;46(8-9):1867-77
– reference: 17898229 - J Neurosci. 2007 Sep 26;27(39):10578-87
– reference: 12519925 - N Engl J Med. 2003 Jan 9;348(2):138-50
– reference: 20981514 - J Physiol Biochem. 2011 Mar;67(1):129-39
– reference: 20081871 - Nat Rev Immunol. 2010 Feb;10(2):89-102
– reference: 22273282 - Am Surg. 2012 Jan;78(1):1-8
– reference: 16354768 - Mol Pharmacol. 2006 Mar;69(3):1041-7
– reference: 21666060 - J Immunol. 2011 Jul 15;187(2):718-25
– reference: 12057007 - Biochem J. 2002 Oct 1;367(Pt 1):97-105
– reference: 19741199 - Am J Physiol Cell Physiol. 2009 Nov;297(5):C1294-306
– reference: 22224768 - Annu Rev Immunol. 2012;30:313-35
– reference: 11861600 - Annu Rev Immunol. 2002;20:125-63
– reference: 15241416 - Nature. 2004 Jul 8;430(6996):218-22
– reference: 15502843 - Nat Med. 2004 Nov;10(11):1216-21
– reference: 19525145 - Curr Opin Pharmacol. 2009 Aug;9(4):514-20
– reference: 19502795 - Cell Cycle. 2009 Jul 1;8(13):2019-23
– reference: 23519622 - Basic Res Cardiol. 2013 May;108(3):345
– reference: 18042700 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19291-6
– reference: 18500366 - Br J Pharmacol. 2008 Aug;154(8):1558-71
– reference: 21691078 - Cell Physiol Biochem. 2011;27(5):605-12
– reference: 22224773 - Annu Rev Immunol. 2012;30:295-312
– reference: 19345327 - Cancer Cell. 2009 Apr 7;15(4):283-93
– reference: 21131957 - Nat Med. 2011 Jan;17(1):64-70
– reference: 20706987 - Eur J Immunol. 2010 Sep;40(9):2580-9
– reference: 24018376 - Cell Res. 2013 Nov;23(11):1249-50
– reference: 21921156 - Science. 2011 Oct 7;334(6052):98-101
– reference: 9034191 - Nature. 1997 Feb 20;385(6618):733-6
– reference: 17911593 - J Immunol. 2007 Oct 15;179(8):5082-9
– reference: 19626115 - Nature. 2009 Jul 23;460(7254):529-33
– reference: 12490957 - Nature. 2002 Dec 19-26;420(6917):846-52
– reference: 21122157 - Mol Cancer. 2010;9:309
– reference: 14534236 - J Neurosci. 2003 Oct 8;23(27):9024-31
– reference: 18723372 - Cytokine. 2008 Oct;44(1):126-34
– reference: 11060664 - Expert Opin Investig Drugs. 2000 Jan;9(1):103-11
– reference: 12033742 - Nat Rev Immunol. 2002 May;2(5):364-71
– reference: 18975306 - Arthritis Rheum. 2008 Nov;58(11):3439-49
– reference: 12508119 - Nature. 2003 Jan 23;421(6921):384-8
– reference: 16056392 - Nat Rev Drug Discov. 2005 Aug;4(8):673-84
– reference: 22696253 - Stem Cells. 2012 Aug;30(8):1746-55
– reference: 21810260 - J Transl Med. 2011;9:129
– reference: 18669662 - Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13
– reference: 19483718 - Nat Immunol. 2009 Jul;10(7):744-52
– reference: 16393953 - J Immunol. 2006 Jan 15;176(2):721-5
– reference: 19596990 - J Immunol. 2009 Aug 1;183(3):2150-8
– reference: 10839541 - Nature. 2000 May 25;405(6785):458-62
– reference: 20859658 - Pharm Res. 2011 Feb;28(2):413-6
– reference: 18650913 - Nature. 2008 Jul 24;454(7203):428-35
– reference: 21652514 - Int Immunol. 2011 Jul;23(7):421-5
– reference: 17709479 - J Immunol. 2007 Sep 1;179(5):2686-9
– reference: 22153071 - Cell. 2011 Dec 9;147(6):1233-47
– reference: 16025117 - Nat Immunol. 2005 Aug;6(8):844-51
SSID ssj0025451
Score 2.5279498
Snippet The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine...
The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine...
The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the alpha 7-nicotinic acetylcholine...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1270
SubjectTerms 631/250/127
631/250/2504/342
631/250/256
631/337/384/331
Acetylcholine receptors
ADAM Proteins - metabolism
ADAM17 Protein
alpha7 Nicotinic Acetylcholine Receptor - metabolism
Animals
Biomedical and Life Sciences
Cell Biology
Cells, Cultured
Cholinergic Neurons - metabolism
Cytokines - biosynthesis
Cytokines - genetics
Cytokines - secretion
HEK293 Cells
Humans
Interleukin-6 - biosynthesis
Interleukin-6 - genetics
Life Sciences
Lipopolysaccharides - antagonists & inhibitors
Lipopolysaccharides - pharmacology
Macrophages - metabolism
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
MicroRNAs - metabolism
Original
original-article
Sepsis - chemically induced
Sepsis - genetics
Sepsis - metabolism
Sepsis - pathology
siRNA
STAT3
STAT3 Transcription Factor - metabolism
TNF-α
Transcription, Genetic
Tumor Necrosis Factor-alpha - biosynthesis
Tumor Necrosis Factor-alpha - genetics
乙酰胆碱受体
介导
抗炎作用
细胞因子
胆碱能
Title MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines
URI http://lib.cqvip.com/qk/85240X/201311/47769860.html
https://link.springer.com/article/10.1038/cr.2013.116
https://www.ncbi.nlm.nih.gov/pubmed/23979021
https://www.proquest.com/docview/1448240721
https://www.proquest.com/docview/1449282100
https://www.proquest.com/docview/1464503031
https://pubmed.ncbi.nlm.nih.gov/PMC3817544
Volume 23
WOSCitedRecordID wos000326683600009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1748-7838
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0025451
  issn: 1001-0602
  databaseCode: M7P
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1748-7838
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0025451
  issn: 1001-0602
  databaseCode: 7X7
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1748-7838
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0025451
  issn: 1001-0602
  databaseCode: BENPR
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9RADLZoC1IvPAqlKWUVpHJBiprnPE6oVK24sFpVIO0tmkwmbNSSbHe3SL3w27FnksB2US9cIkXjTDKyx2PH9meAY2m4NjrRQSm1CFLcTUFRFujzJGjKKVWEkhe22QQfj8V0KifdD7dll1bZ60SrqMtW0z_yEzT8hUPz-ji_CahrFEVXuxYaW7BDKAmxTd2bDA4XWgfW4bJpQ4wyefZcmbk40YQFGiWoMSyqwqxtvt_gWbF-Om2YnJuZk_fCp_ZUunj2v-t5Dk87e9Q_dQL0Ah6ZZg-euA6Vdy_h1xdK2LscnwZ4Qvu2zARtUx-tRp_0pq0crLWP7KkDlFUUrx82bO-7egm_awPk182sLmpKsbbPzh3OLFG0Fd2tP6zvVu0V5eO_gm8X51_PPgddy4ZAZzxaBYpX3Jg0K6SOyjgOjaziMokizQyThYkqZdCHKnVWRIlCS1LiaBkrZggfWaGxuQ_bTduYA_A1um5G4dEZViJNy0TFspJRxUqBU-lQe3A4sC2fO2iOPOWcScFCDz70fMx1B3ZOPTeucxt0T0SuFzkJAHpAzIPjgbif6J9kRz0n826jL_M_bPTg3TCMW5TiLqox7a2lkejZohg-RMPSDBVugvO8djI2fEtMsdeQ3sDXpG8gIIjw9ZGmnlmocMJfzNLUg_e9nP716ZtLPHx4iW9glyhdKeYRbK8Wt-YtPNY_V_VyMYItPuX2Kkaw8-l8PLkc2f34G-zQPZk
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3fb9MwED5NG4i9DBgwMgYYaXtBipbfjh8QmoBp07YKoSH1LTiOQyMg6doO1Bf-JP5G7uwkoxTtbQ88Vj67cXt3_i6--w5gV2iutAqVWwiVuhFak5sXOcY8IUI5KXNP8Nw0m-CDQTocivcr8KurhaG0ys4nGkddNIreke8j8E8tm9fr8YVLXaPodrVroWHV4kTPf2DINn11_Bb_370gOHx3_ubIbbsKuCrm_syVvORaR3EulF8EgadFGRSh76tEJyLXfik1wvxCxbkfSgQ7AkeLQCaaKHylIKIDdPlr6Mc5BXt8eBXgIRoxAZ5JU0ooc2jTlrWn-4q4R_0QPZRhcRg19ecLPJsWT8MliLucqfnXda05BQ_v_m-_3z3YaPE2O7AGch9WdL0Jt20HzvkD-HlGCYkfBgcuIhBmymgQezNExYzOBVMZWSmG6le5aItoPt9MWgKz9SCsbXPEqnpU5RWlkJu5Y8ujSxJNSZ8WJ6v5rPlC9QYP4eONbP4RrNZNrR8DUxiaaonQwCvTKCpCGYhS-GVSpLiU8pQD272aZGNLPZJFnCciTTwHXnZ6k6mWzJ16inzNTFJBmGZqkpHCYYSXOLDbC3cL_VNsp9OcrHVk0-xKbRx40Q-jC6J7JVnr5tLICIzcUe2vk0miGA-UENfZsjrdP0tAd8sefQNf0PZegCjQF0fqamSo0IlfMo4iB_Y6u_jj0Ze3uH39Fp_DnaPzs9Ps9Hhw8gTWaZYtO92B1dnkUj-FW-r7rJpOnhm7Z_Dppg3lN7EZl_Q
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB5VKSAuPAoFlwJGai9IVvxe7wGhQhtRFayoAqk3s16viQXYaZKCcuGH8euY2bUNIai3HjhGO7vxJjOz33hnvgHY44pJJQPpFFwmTojW5ORFjjFPgFBOiNzlLNfNJliaJmdnfLwBP7taGEqr7HyidtRFI-kd-RCBf2LYvIZlmxYxPhy9nJ471EGKblq7dhpGRU7U8juGb_MXx4f4X-_7_ujo_es3TtthwJER8xaOYCVTKoxyLr3C913FS78IPE_GKua58kqhEPIXMsq9QCDw4Tha-CJWROcrOJEeoPvfZAgywgFsvjpKx6d9uIfYRId7OmkppjyiLVPkngwlMZF6AforzekwaepP53hSrZ6Na4B3PW_zr8tbfSaObv_Pv-YduNUicfvAmM5d2FD1Flw3vTmX9-DHO0pVPE0PHMQmti6wQVRuI1626cTQNZOVtFExKwetFA3rq05YsE2liN02QLKrelLlFSWX67lTw7BLEk1Jn1Yny-Wi-UyVCPfhw5VsfhsGdVOrh2BLDFqVQNDglkkYFoHwecm9Mi4SXEq60oKdXmWyqSElyULGYp7ErgXPOx3KZEvzTt1GvmQ63SBIMjnLSPkw9ost2OuFu4X-KbbbaVHWurh59luFLHjWD6NzohsnUavmQstwjOnRBC6TicMIj5oA13lg9Lt_Fp9unV36Brai-b0AkaOvjtTVRJOkE_NkFIYW7Hc28sejr29x5_ItPoUbaB_Z2-P05BHcpEmmHnUXBovZhXoM1-S3RTWfPWmdgA0fr9pSfgFQNKIU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-124+mediates+the+cholinergic+anti-inflammatory+action+through+inhibiting+the+production+of+pro-inflammatory+cytokines&rft.jtitle=Cell+research&rft.au=Sun%2C+Yang&rft.au=Li%2C+Qi&rft.au=Gui%2C+Huan&rft.au=Xu%2C+Dong-ping&rft.date=2013-11-01&rft.pub=Nature+Publishing+Group&rft.issn=1001-0602&rft.eissn=1748-7838&rft.volume=23&rft.issue=11&rft.spage=1270&rft_id=info:doi/10.1038%2Fcr.2013.116&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3116501101
thumbnail_s http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85240X%2F85240X.jpg